Clinical trial
Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent…
NCT00005037 · Fox Chase Cancer Center, Other · Completed
Key facts
| NCT number | NCT00005037 |
|---|---|
| Title | Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer |
| Official title | Temozolomide in the Treatment of Advanced Non-Small Cell Lung Carcinoma: Phase II Evaluation in Previously Treated and Chemo-Naive Patients |
| Lead sponsor | Fox Chase Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | temozolomide, Temozolomide |
| Enrollment | 51 |
| Start date | Jan 1, 2000 |
| Primary completion | Oct 1, 2002 |
| Completion | Apr 1, 2008 |
| First posted | Mar 16, 2004 |
| Last update posted | May 6, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: